Keywords: thalomid, debuts, market, celgene, thalidomide-based, product, treatment

Thalomid Debuts On US Market

Article | 06 October 1998

Celgene's thalidomide-based product for the treatment of cutaneousmanifestations of moderate-to-severe erythema nodosum leprosum, Thalomid, has now been launched in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Thalidomide

Thalomid

Go to drug listing